Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non-Pharmacological Therapy. [PDF]
Kanazawa H +12 more
europepmc +1 more source
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study. [PDF]
Razvi Y +16 more
europepmc +1 more source
p.Asp58Val Hereditary Transthyretin Amyloidosis: A Case Report and Literature Review. [PDF]
Ramnarain J, Hosking P, Gibbs S.
europepmc +1 more source
Wild Type Transthyretin Amyloid Cardiomyopathy Hidden Under Ablation-Refractory Atrial Arrhythmias and the Potential Contribution of Tafamidis in Rhythm Control. [PDF]
Horie T +4 more
europepmc +1 more source
Bridging the Gap in AL and ATTR Cardiac Amyloidosis: Integrating Histopathology, Biomarkers, and Multimodal Imaging for Subtype-Specific Diagnosis. [PDF]
Ali K +7 more
europepmc +1 more source
Transthyretin amyloid cardiomyopathy: from cause to novel treatments. [PDF]
Fontana M +6 more
europepmc +1 more source
Amyloidogenic phenotypical variation affects post-transplant outcome of hereditary transthyretin amyloidosis: a retrospective study. [PDF]
Wilczek HE +3 more
europepmc +1 more source
Investigation of Acoramidis-based ionic liquids as potential stabilizers of transthyretin using DFT calculations, molecular docking, and ADMET studies. [PDF]
Mostaghni F, Mahani NM.
europepmc +1 more source
Multimodal Diagnosis of Cardiac Amyloidosis: Integrating Imaging, Histochemistry, and Proteomics of Precise Typing. [PDF]
Kancerek J +3 more
europepmc +1 more source

